Literature DB >> 19472619

Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula.

Uwe Schneider1.   

Abstract

A simple mechanistic model for predicting cancer induction after fractionated radiotherapy is developed. The model is based upon the linear-quadratic model. The inductions of carcinomas and sarcomas are modeled separately. The linear-quadratic model of cell kill is applied to normal tissues which are unintentionally irradiated during a cancer treatment with radiotherapy. Tumor induction is modeled such that each transformation process results in a tumor cell. The microscopic transformation parameter was chosen such that in the limit of low dose and acute exposure, the parameters of the linear-no-threshold model for tumor induction were approached. The differential equations describing carcinoma and sarcoma inductions can be solved analytically. Cancer induction in this model is a function of treatment dose, the cell kill parameters (alpha, beta), the tumor induction variable (mu), and the repopulation parameter (zeta). Carcinoma induction shows a bell shaped behavior as long as cell repopulation is small. Assuming large cell repopulation rates, a plateaulike function is approached. In contrast, sarcoma induction is negligible for low doses and increases with increasing dose up to a constant value. The proposed model describes carcinoma and sarcoma inductions after fractionated radiotherapy as an analytical function of four parameters. In the limit of low dose and for an instant irradiation it reproduces the results of the linear-no-threshold model. The obtained dose-response curves for cancer induction can be implemented with other models such as the organ-equivalent dose model to predict second cancers after radiotherapy.

Entities:  

Mesh:

Year:  2009        PMID: 19472619     DOI: 10.1118/1.3089792

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  39 in total

1.  Model of accelerated carcinogenesis based on proliferative stress and inflammation for doses relevant to radiotherapy.

Authors:  Uwe Schneider; Brigitte Schäfer
Journal:  Radiat Environ Biophys       Date:  2012-08-17       Impact factor: 1.925

2.  Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses.

Authors:  J Nguyen; M Moteabbed; H Paganetti
Journal:  Med Phys       Date:  2015-01       Impact factor: 4.071

3.  Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?

Authors:  B Knäusl; C Lütgendorf-Caucig; J Hopfgartner; K Dieckmann; L Kurch; T Pelz; R Pötter; D Georg
Journal:  Strahlenther Onkol       Date:  2012-11-18       Impact factor: 3.621

4.  Modeling age-dependent radiation-induced second cancer risks and estimation of mutation rate: an evolutionary approach.

Authors:  Kamran Kaveh; Venkata S K Manem; Mohammad Kohandel; Siv Sivaloganathan
Journal:  Radiat Environ Biophys       Date:  2014-11-18       Impact factor: 1.925

5.  Dosimetric trade-offs in breast treatment with VMAT technique.

Authors:  Antonella Fogliata; Jan Seppälä; Giacomo Reggiori; Francesca Lobefalo; Valentina Palumbo; Fiorenza De Rose; Davide Franceschini; Marta Scorsetti; Luca Cozzi
Journal:  Br J Radiol       Date:  2017-01-03       Impact factor: 3.039

6.  Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.

Authors:  Shunsuke Suzuki; Takahiro Kato; Masao Murakami
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

7.  Second Cancer Risk after simultaneous integrated boost radiation therapy of right sided breast cancer with and without flattening filter.

Authors:  Barbara Dobler; Johannes Maier; Bernadette Knott; Manuel Maerz; Rainer Loeschel; Oliver Koelbl
Journal:  Strahlenther Onkol       Date:  2016-08-17       Impact factor: 3.621

8.  Tumour size can have an impact on the outcomes of epidemiological studies on second cancers after radiotherapy.

Authors:  Uwe Schneider; Linda Walsh; Wayne Newhauser
Journal:  Radiat Environ Biophys       Date:  2018-08-31       Impact factor: 1.925

Review 9.  Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy.

Authors:  Harald Paganetti
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

10.  Hypofractionated radiotherapy has the potential for second cancer reduction.

Authors:  Uwe Schneider; Jürgen Besserer; Andreas Mack
Journal:  Theor Biol Med Model       Date:  2010-02-11       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.